Solid Tumor
📧 Sign up to get email alerts when something new happens for Solid Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: Pilot Trial of Colchicine in Urothelial Cancer and Other Solid Tumors [Phase 1]
A Phase 1 pilot trial evaluating colchicine in urothelial cancer and other metastatic solid tumors has completed. The study, sponsored by Ic…
-
CLINICAL_TRIALS trial_result · 2024-12-20Clinical Trial Update: Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer [Phase 1, Phase 2]
Phase 1/2 study assessing safety, tolerability, and preliminary efficacy of CJRB-101 in combination with pembrolizumab in selected advanced …
-
CLINICAL_TRIALS research · 2024-12-20Clinical Trial Update: OH2 Oncolytic Viral Therapy in Solid Tumors [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial of OH2 oncolytic viral therapy for solid tumors and gastrointestinal cancers is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-12-18Clinical Trial Update: A Phase Ib/II Study of BY101298 , an Oral DNA-PK Inhibitor, Combined with Radiotherapy in Patients with Malignant Solid Tumors [Phase 1, Phase 2]
A Phase Ib/II study of BY101298, an oral DNA-PK inhibitor, in combination with radiotherapy for malignant solid tumors has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-12-12Clinical Trial Update: First-in-Human Study of the SHP2 Inhibitor BBP-398 in Patients With Advanced Solid Tumors [Phase 1]
First-in-human study of the SHP2 inhibitor BBP-398 in advanced solid tumors has been terminated (Phase 1).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-12-04Clinical Trial Update: Study of 23ME-01473 in Patients With Advanced Solid Malignancies [Phase 1, Phase 2]
A clinical trial evaluating 23ME-01473 in advanced solid malignancies (Phase 1/2) conducted by 23andMe, Inc. has been terminated.
-
CLINICAL_TRIALS research · 2024-12-03Clinical Trial Update: A Safety and Efficacy Study of Allogeneic CAR Gamma-Delta T Cells in Subjects with Relapsed/Refractory Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating allogeneic CAR gamma-delta T cells in patients with relapsed or refractory solid tumors; currently rec…
-
CLINICAL_TRIALS research · 2024-12-02Clinical Trial Update: TLD-1, a Novel Liposomal Doxorubicin, in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 study of TLD-1, a novel liposomal doxorubicin, in patients with advanced solid tumors; the trial status was terminated.
-
CLINICAL_TRIALS trial_result · 2024-11-29Clinical Trial Update: A Study of ABM-1310 in Patients With BRAF V600-Mutant Advanced Solid Tumors [Phase 1]
A Phase 1 trial of ABM-1310 in patients with BRAF V600-mutant advanced solid tumors has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: A Study of AB-106 in Chinese Healthy Adult Men Evaluated the Effects of Itraconazole and Rifampicin on AB-106 PK [Phase 1]
Phase 1 pharmacokinetic study evaluating the effects of itraconazole and rifampicin on AB-106 in Chinese healthy adult men to assess potenti…
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: A Study on the Effect of AB-106 on the Pharmacokinetics of Digoxin [Phase 1]
Phase 1 trial completed to evaluate the effect of AB-106 on the pharmacokinetics of digoxin in patients with solid tumors.
-
CLINICAL_TRIALS trial_result · 2024-11-20Clinical Trial Update: Study of Allogeneic Blood-derived Natural Killer Cells to Evaluate Safety and Tolerability in Cancer Refractory to Conventional Therapy [Phase 1]
Phase 1 study evaluating the safety and tolerability of allogeneic blood-derived natural killer cells in cancers refractory to conventional …
-
CLINICAL_TRIALS research · 2024-11-12Clinical Trial Update: Safety and Tolerability Study for T-1301 Capsules to Treat Advanced Solid Tumors [Phase 1]
A Phase 1 safety and tolerability study of T-1301 capsules for advanced solid tumors and lymphoma is currently recruiting.
-
CLINICAL_TRIALS withdrawal · 2024-10-31Clinical Trial Update: Itacitinib for the Treatment Steroid Refractory Immune Related Adverse Events Arising From Immune Checkpoint Inhibitors [Phase 2]
Phase 2 trial of itacitinib for treating steroid-refractory immune-related adverse events from immune checkpoint inhibitors has been withdra…
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: Onalespib, Dabrafenib, and Trametinib in Treating Patients With BRAF-Mutant Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery [Phase 1]
This Phase 1 trial assessed the combination of onalespib with dabrafenib and trametinib in patients with BRAF-mutant melanoma or metastatic/…
-
CLINICAL_TRIALS research · 2024-10-10Clinical Trial Update: Clinical Trial of HG146 Administered to Subjects with Advanced Solid Tumors or Lymphoma [Phase 1]
This entry reports a Phase 1 study of HG146 in subjects with advanced solid tumors or lymphoma. The sponsor is HitGen Inc., and the current …
-
CLINICAL_TRIALS research · 2024-10-03Clinical Trial Update: A Non-interventional, International, Multicentre Clinical Research Study to Build the Largest Collection of Multimodal Data (Including Clinical Data, Imaging Data and Omics Data) in Oncology
An international non-interventional study sponsored by OWKIN to build a large multimodal oncology data resource (clinical, imaging, and omic…
-
CLINICAL_TRIALS trial_result · 2024-10-02Clinical Trial Update: Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatric Cancer [Phase 1]
Phase 1 study of BRD/BET inhibitors BMS-986158 and BMS-986378 in pediatric cancers has completed enrollment.
-
CLINICAL_TRIALS trial_result · 2024-09-27Clinical Trial Update: Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors [Phase 1]
Phase 1 pharmacokinetic drug-drug interaction study evaluating encorafenib and binimetinib on probe drugs in patients with BRAF V600-mutant …
-
CLINICAL_TRIALS research · 2024-09-26Clinical Trial Update: A Study of HDM2005 in Patients With Relapsed/Refractory B-cell Lymphoma and Advanced Solid Tumor [Phase 1]
This clinical trial update notes a Phase 1 study of the investigational therapy HDM2005 in patients with relapsed or refractory B-cell lymph…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: First-in-Human Study of EOS100850 (Inupadenant) in Patients with Cancer [Phase 1]
A first-in-human Phase 1 study of EOS100850 (Inupadenant) in adults with solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Circulating Tumor DNA As Liquid Biopsy in Patients with Stage IV Solid Tumors, a Feasibility Study At MUSC HCC
This is a completed feasibility study at the Medical University of South Carolina evaluating circulating tumor DNA as a liquid biopsy in adu…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Distress Associated with Coronavirus Disease 2019 and Telehealth on Supportive Care Patients with Advanced Cancer
This clinical trial update examines distress associated with COVID-19 and the use of telehealth in supportive-care patients with advanced ca…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: High Definition Medicine for Solid Tumors Oncology
A clinical trial led by Centro Nacional de Investigaciones Oncologicas Carlos III is currently recruiting to evaluate High Definition Medici…
-
CLINICAL_TRIALS trial_result · 2024-09-04Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of Injectable PEG-Irinotecan (JK-1201I) in Patients with Malignant Solid Tumor [Phase 1]
A Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of the injectable PEGylated irinotecan JK-1201I in patients with m…